课题基金 / 基金详情

Protecting the Maternal Heart From Pregnancy-Associated Heart Disease

Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
保护母亲心脏免受妊娠相关心脏病的影响
批准号:
9762134
负责人:
MICHELLE L MATTER
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-13 至 2023-06-30

项目摘要

项目成果

MICHELLE L MATTER的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary Postpartum cardiomyopathy (PPCM) is a disease of unknown etiology that arises as a complication of pregnancy in women with no prior heart disease. It occurs in 1:1800 to 1:3500 births in the United States and is characterized by an acute onset of heart failure during the last month of pregnancy or within five months postpartum. PPCM is a major cause of maternal morbidity and mortality with no PPCM-specific treatment options available. During pregnancy, pregnancy-associated hypertrophy initiates the activation of cardiomyocyte protective signaling pathways that block stress-mediated apoptosis. In PPCM patients there is an increase in cardiomyocyte apoptosis that leads to irreversible dysfunction and heart failure. The cellular mechanisms driving cardiomyocyte apoptosis are not fully understood. We have identified a gene PTRH2 (also called Bit-1) that is evolutionarily conserved, mediates integrin regulated cell survival and apoptosis, and mutations in this gene promote multisystem disease in humans. We hypothesize that PTRH2 is essential for cardioprotection from peripartum stresses in the maternal heart. To study this we developed a cardiomyocyte-specific deletion of PTRH2 (CKO). CKO male and never- pregnant female mice demonstrate no heart defects and live to old age. However, 100% of CKO pregnant female mice develop PPCM in a dose-dependent manner (CKO>HET). We will use cell and molecular biology and our CKO mice to determine how PTRH2 mediates cardioprotection, test whether PTRH2 associated proteins abrogate the PPCM phenotype in CKO pregnant mice, determine whether PTRH2 expression blocks hypertrophy and examine PPCM patient heart samples for PTRH2 gene mutations. The proposed project has the potential to identify an essential survival pathway that is activated in pregnancy-associated hypertrophy, test PTRH2 directed therapeutic strategies in a preclinical mouse model of PPCM and determine whether mutations in PTRH2 promote PPCM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protecting the maternal heart from pregnancy associated heart disease
  • 批准号:
    10767091
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2023
  • 负责人:
    MICHELLE L MATTER
  • 依托单位:
Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
  • 批准号:
    10438833
  • 项目类别:
  • 资助金额:
    $2.31万
  • 财政年份:
    2018
  • 负责人:
    MICHELLE L MATTER
  • 依托单位:
Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
  • 批准号:
    10192771
  • 项目类别:
  • 资助金额:
    $38.5万
  • 财政年份:
    2018
  • 负责人:
    MICHELLE L MATTER
  • 依托单位:
Regulation of endothelial permeability in sepsis
  • 批准号:
    8525409
  • 项目类别:
  • 资助金额:
    $27.86万
  • 财政年份:
    2012
  • 负责人:
    MICHELLE L MATTER
  • 依托单位:
海外基金